These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 30076000)

  • 61. Development of an oligonucleotide-based fluorescence assay for the identification of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors.
    Walker S; Meisenberg C; Bibby RA; Askwith T; Williams G; Rininsland FH; Pearl LH; Oliver AW; El-Khamisy S; Ward S; Atack JR
    Anal Biochem; 2014 Jun; 454(100):17-22. PubMed ID: 24637157
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel deazaflavin tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors.
    Kiselev E; Ravji A; Kankanala J; Xie J; Wang Z; Pommier Y
    DNA Repair (Amst); 2020 Jan; 85():102747. PubMed ID: 31775111
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Antitumor Activity of the Combination of Topotecan and Tyrosyl-DNA-Phosphodiesterase 1 Inhibitor on Model Krebs-2 Mouse Ascite Carcinoma].
    Dyrkheeva NS; Zakharenko AL; Novoselova ES; Chepanova AA; Popova NA; Nikolin VP; Luzina OA; Salakhutdinov NF; Ryabchikova EI; Lavrik OI
    Mol Biol (Mosk); 2021; 55(2):312-317. PubMed ID: 33871444
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Usnic Acid Derivatives Inhibit DNA Repair Enzymes Tyrosyl-DNA Phosphodiesterases 1 and 2 and Act as Potential Anticancer Agents.
    Zakharenko AL; Dyrkheeva NS; Luzina OA; Filimonov AS; Mozhaitsev ES; Malakhova AA; Medvedev SP; Zakian SM; Salakhutdinov NF; Lavrik OI
    Genes (Basel); 2023 Oct; 14(10):. PubMed ID: 37895279
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A fluorescence-based assay for the apurinic/apyrimidinic-site cleavage activity of human tyrosyl-DNA phosphodiesterase 1.
    Thomson GJ; Hamilton NS; Hopkins GV; Waddell ID; Watson AJ; Ogilvie DJ
    Anal Biochem; 2013 Sep; 440(1):1-5. PubMed ID: 23688965
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Influence of Tyrosyl-DNA Phosphodiesterase 1 Inhibitor on the Proapoptotic and Genotoxic Effects of Anticancer Agent Topotecan.
    Chepanova AA; Zakharenko AL; Dyrkheeva NS; Chernyshova IA; Zakharova OD; Ilina ES; Luzina OA; Salakhutdinov NF; Lavrik OI
    Dokl Biochem Biophys; 2023 Feb; 508(1):25-30. PubMed ID: 36653585
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biochemical assays for the discovery of TDP1 inhibitors.
    Marchand C; Huang SY; Dexheimer TS; Lea WA; Mott BT; Chergui A; Naumova A; Stephen AG; Rosenthal AS; Rai G; Murai J; Gao R; Maloney DJ; Jadhav A; Jorgensen WL; Simeonov A; Pommier Y
    Mol Cancer Ther; 2014 Aug; 13(8):2116-26. PubMed ID: 25024006
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pre-steady state kinetics of DNA binding and abasic site hydrolysis by tyrosyl-DNA phosphodiesterase 1.
    Kuznetsov NA; Lebedeva NA; Kuznetsova AA; Rechkunova NI; Dyrkheeva NS; Kupryushkin MS; Stetsenko DA; Pyshnyi DV; Fedorova OS; Lavrik OI
    J Biomol Struct Dyn; 2017 Aug; 35(11):2314-2327. PubMed ID: 27687298
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Direct interaction of DNA repair protein tyrosyl DNA phosphodiesterase 1 and the DNA ligase III catalytic domain is regulated by phosphorylation of its flexible N-terminus.
    Rashid I; Hammel M; Sverzhinsky A; Tsai MS; Pascal JM; Tainer JA; Tomkinson AE
    J Biol Chem; 2021 Aug; 297(2):100921. PubMed ID: 34181949
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Novel Tdp1 Inhibitors Based on Adamantane Connected with Monoterpene Moieties via Heterocyclic Fragments.
    Munkuev AA; Mozhaitsev ES; Chepanova AA; Suslov EV; Korchagina DV; Zakharova OD; Ilina ES; Dyrkheeva NS; Zakharenko AL; Reynisson J; Volcho KP; Salakhutdinov NF; Lavrik OI
    Molecules; 2021 May; 26(11):. PubMed ID: 34073771
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Discovery of Novel Sultone Fused Berberine Derivatives as Promising Tdp1 Inhibitors.
    Gladkova ED; Chepanova AA; Ilina ES; Zakharenko AL; Reynisson J; Luzina OA; Volcho KP; Lavrik OI; Salakhutdinov NF
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33808389
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Epigenetic and genetic inactivation of tyrosyl-DNA-phosphodiesterase 1 (TDP1) in human lung cancer cells from the NCI-60 panel.
    Gao R; Das BB; Chatterjee R; Abaan OD; Agama K; Matuo R; Vinson C; Meltzer PS; Pommier Y
    DNA Repair (Amst); 2014 Jan; 13():1-9. PubMed ID: 24355542
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Repair of topoisomerase I covalent complexes in the absence of the tyrosyl-DNA phosphodiesterase Tdp1.
    Liu C; Pouliot JJ; Nash HA
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14970-5. PubMed ID: 12397185
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tyrosyl-DNA phosphodiesterase (Tdp1) participates in the repair of Top2-mediated DNA damage.
    Nitiss KC; Malik M; He X; White SW; Nitiss JL
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):8953-8. PubMed ID: 16751265
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tyrosyl-DNA-phosphodiesterase I (TDP1) participates in the removal and repair of stabilized-Top2α cleavage complexes in human cells.
    Borda MA; Palmitelli M; Verón G; González-Cid M; de Campos Nebel M
    Mutat Res; 2015 Nov; 781():37-48. PubMed ID: 26421495
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation.
    Balupuri A; Lee MH; Chae S; Jung E; Yoon W; Kim Y; Son SJ; Ryu J; Kang DH; Yang YJ; You JN; Kwon H; Jeong JW; Koo TS; Lee DY; Kang NS
    Eur J Med Chem; 2018 Mar; 148():397-409. PubMed ID: 29477073
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Tyrosyl-DNA phosphodiesterase (Tdp1) (3'-phosphotyrosyl DNA phosphodiesterase).
    Raymond AC; Burgin AB
    Methods Enzymol; 2006; 409():511-24. PubMed ID: 16793421
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inhibitors of human tyrosyl-DNA phospodiesterase (hTdp1) developed by virtual screening using ligand-based pharmacophores.
    Weidlich IE; Dexheimer T; Marchand C; Antony S; Pommier Y; Nicklaus MC
    Bioorg Med Chem; 2010 Jan; 18(1):182-9. PubMed ID: 19963390
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synthesis and structure-activity relationship of furoquinolinediones as inhibitors of Tyrosyl-DNA phosphodiesterase 2 (TDP2).
    Yu LM; Hu Z; Chen Y; Ravji A; Lopez S; Plescia CB; Yu Q; Yang H; Abdelmalak M; Saha S; Agama K; Kiselev E; Marchand C; Pommier Y; An LK
    Eur J Med Chem; 2018 May; 151():777-796. PubMed ID: 29677635
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Transcriptomic analysis of HEK293A cells with a CRISPR/Cas9-mediated TDP1 knockout.
    Dyrkheeva NS; Zakharenko AL; Malakhova AA; Okorokova LS; Shtokalo DN; Medvedev SP; Tupikin AA; Kabilov MR; Lavrik OI
    Biochim Biophys Acta Gen Subj; 2024 Jul; 1868(7):130616. PubMed ID: 38621596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.